Expression and significance of angiopoietin-2 in gastric cancer

AIM: To investigate the expression and pathological factors of Angiopoietin-2 (Ang-2) in primary gastric cancers and adjacent normal tissues. METHODS: The expression of Angiopoietin-2 and VEGF were studied in 72 primary gastric cancers and adjacent normal tissues from the same patients by semi-quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and immumohistochemistry. RESULTS: Ang-2 was mainly expression in tumor cells. There were significantly difference between expression of Ang-2 in primary gastric cancer and in adjacent normal tissue samples (P = 0.003). It was statistically correlation between Ang-2 and VEGF expression in tumors (P = 0.0055). With regard to Ang-2 expression in tumors, there were significant difference between early stage and advanced stage (P = 0.017), and significant difference between positive vascular involvement and negative vascular involvement (P = 0.032). However, there was no significant difference between moderate-poor differential type and high differential type (P = 0.908), between positive lymph node metastasis and negative lymph node metastasis (P = 0.752), between positive serosal invasion and negative serosal invasion (P = 0.764). The cases with expression of Ang-2 were increasing with advanced stage and vascular involvement. CONCLUSION: The results manifested that Angiopoietin-2, coordinated with VEGF, play role in regulating tumor angiogenesis of gastric cancer.